18F-Flutemetamol PET/CT for Transthyretin Amyloid Cardiomyopathy: Timing Matters

Eun Ji Han; Yeoun Eun Sung; Mi Hyang Jung; Joo Hyun O; Jong Chan Youn

doi:10.1097/RLU.0000000000004411

¹⁸F-Flutemetamol PET/CT for Transthyretin Amyloid Cardiomyopathy: Timing Matters

Eun Ji Han, Yeoun Eun Sung, Mi Hyang Jung, Joo Hyun O, Jong Chan Youn

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

We report 18F-flutemetamol PET/CT finding in an 88-year-old man with cognitive impairment and transthyretin amyloid cardiomyopathy. Early phase PET/CT images showed significantly increased myocardial uptake, but there was no myocardial uptake in delayed phase PET/CT images. A dual-time-point amyloid PET/CT imaging may be helpful to diagnose and differentiate subtypes of amyloid cardiomyopathy in patients with suspected cardiac amyloidosis.

Original language	English
Pages (from-to)	1074-1076
Number of pages	3
Journal	Clinical Nuclear Medicine
Volume	47
Issue number	12
DOIs	https://doi.org/10.1097/RLU.0000000000004411
State	Published - 1 Dec 2022

Bibliographical note

Publisher Copyright:
© Wolters Kluwer Health, Inc. All rights reserved.

Keywords

ATTR
F-flutemetamol
amyloid PET
cardiac amyloidosis

Access to Document

10.1097/RLU.0000000000004411

Cite this

@article{849ac2d978924aa598953cee667b7ead,

title = "18F-Flutemetamol PET/CT for Transthyretin Amyloid Cardiomyopathy: Timing Matters",

abstract = "We report 18F-flutemetamol PET/CT finding in an 88-year-old man with cognitive impairment and transthyretin amyloid cardiomyopathy. Early phase PET/CT images showed significantly increased myocardial uptake, but there was no myocardial uptake in delayed phase PET/CT images. A dual-time-point amyloid PET/CT imaging may be helpful to diagnose and differentiate subtypes of amyloid cardiomyopathy in patients with suspected cardiac amyloidosis.",

keywords = "ATTR, F-flutemetamol, amyloid PET, cardiac amyloidosis",

author = "Han, {Eun Ji} and Sung, {Yeoun Eun} and Jung, {Mi Hyang} and {Hyun O}, Joo and Youn, {Jong Chan}",

year = "2022",

month = dec,

day = "1",

doi = "10.1097/RLU.0000000000004411",

language = "English",

volume = "47",

pages = "1074--1076",

journal = "Clinical Nuclear Medicine",

issn = "0363-9762",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "12",

}

TY - JOUR

T1 - 18F-Flutemetamol PET/CT for Transthyretin Amyloid Cardiomyopathy

T2 - Timing Matters

AU - Han, Eun Ji

AU - Sung, Yeoun Eun

AU - Jung, Mi Hyang

AU - Hyun O, Joo

AU - Youn, Jong Chan

PY - 2022/12/1

Y1 - 2022/12/1

N2 - We report 18F-flutemetamol PET/CT finding in an 88-year-old man with cognitive impairment and transthyretin amyloid cardiomyopathy. Early phase PET/CT images showed significantly increased myocardial uptake, but there was no myocardial uptake in delayed phase PET/CT images. A dual-time-point amyloid PET/CT imaging may be helpful to diagnose and differentiate subtypes of amyloid cardiomyopathy in patients with suspected cardiac amyloidosis.

AB - We report 18F-flutemetamol PET/CT finding in an 88-year-old man with cognitive impairment and transthyretin amyloid cardiomyopathy. Early phase PET/CT images showed significantly increased myocardial uptake, but there was no myocardial uptake in delayed phase PET/CT images. A dual-time-point amyloid PET/CT imaging may be helpful to diagnose and differentiate subtypes of amyloid cardiomyopathy in patients with suspected cardiac amyloidosis.

KW - ATTR

KW - F-flutemetamol

KW - amyloid PET

KW - cardiac amyloidosis

UR - http://www.scopus.com/inward/record.url?scp=85141890962&partnerID=8YFLogxK

U2 - 10.1097/RLU.0000000000004411

DO - 10.1097/RLU.0000000000004411

M3 - Article

C2 - 36240762

AN - SCOPUS:85141890962

SN - 0363-9762

VL - 47

SP - 1074

EP - 1076

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

IS - 12

ER -